JP2020509036A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020509036A5 JP2020509036A5 JP2019547373A JP2019547373A JP2020509036A5 JP 2020509036 A5 JP2020509036 A5 JP 2020509036A5 JP 2019547373 A JP2019547373 A JP 2019547373A JP 2019547373 A JP2019547373 A JP 2019547373A JP 2020509036 A5 JP2020509036 A5 JP 2020509036A5
- Authority
- JP
- Japan
- Prior art keywords
- density lipoprotein
- patient
- high density
- composition
- lipoprotein composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023007457A JP2023071648A (ja) | 2017-03-01 | 2023-01-20 | アルツハイマー病を予防的に防止し、その進行を遅らせ、または処置するための方法 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762465262P | 2017-03-01 | 2017-03-01 | |
| US62/465,262 | 2017-03-01 | ||
| US201762516100P | 2017-06-06 | 2017-06-06 | |
| US62/516,100 | 2017-06-06 | ||
| US201762537581P | 2017-07-27 | 2017-07-27 | |
| US62/537,581 | 2017-07-27 | ||
| US15/876,808 US20190021674A1 (en) | 2017-01-23 | 2018-01-22 | Methods for Treating Cholesterol-Related Diseases |
| US15/876,808 | 2018-01-22 | ||
| PCT/US2018/020502 WO2018160868A1 (en) | 2017-03-01 | 2018-03-01 | Methods for prophylactically preventing, slowing the progression of, or treating alzheimer's disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023007457A Division JP2023071648A (ja) | 2017-03-01 | 2023-01-20 | アルツハイマー病を予防的に防止し、その進行を遅らせ、または処置するための方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020509036A JP2020509036A (ja) | 2020-03-26 |
| JP2020509036A5 true JP2020509036A5 (enExample) | 2021-03-25 |
Family
ID=67682480
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019547373A Pending JP2020509036A (ja) | 2017-03-01 | 2018-03-01 | アルツハイマー病を予防的に防止し、その進行を遅らせ、または処置するための方法 |
| JP2023007457A Pending JP2023071648A (ja) | 2017-03-01 | 2023-01-20 | アルツハイマー病を予防的に防止し、その進行を遅らせ、または処置するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023007457A Pending JP2023071648A (ja) | 2017-03-01 | 2023-01-20 | アルツハイマー病を予防的に防止し、その進行を遅らせ、または処置するための方法 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP3589272A4 (enExample) |
| JP (2) | JP2020509036A (enExample) |
| CN (1) | CN110545797A (enExample) |
| AU (1) | AU2018226803A1 (enExample) |
| CA (1) | CA3053491A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019217897A1 (en) * | 2018-05-11 | 2019-11-14 | Hdl Therapeutics, Inc. | Methods for prophylactically preventing, slowing the progression of, or treating cerebral amyloid angiopathy, alzheimer's disease and/or acute stroke |
| CN116662835A (zh) * | 2022-02-18 | 2023-08-29 | 医疗研究开发有限公司 | 分层方法以及分层装置 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2496831A1 (en) * | 2002-08-26 | 2004-03-04 | Lipid Sciences, Inc. | Treating alzheimers using delipidated protein particles |
| JP2007527387A (ja) * | 2003-07-03 | 2007-09-27 | リピッド サイエンシーズ，インコーポレイテッド | 脂質含量の低下したｈｄｌの粒子誘導体を製造するための方法及び装置 |
| SI2089417T1 (sl) * | 2006-10-12 | 2015-04-30 | Bhi Limited Partnership | Metode, spojine, sestavki in vektorji za dostavo 3-amino-1-propansulfonske kisline |
| WO2008103845A2 (en) * | 2007-02-23 | 2008-08-28 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services. | Monoclonal antibodies that neutralize anthrax toxins |
| US9040045B2 (en) * | 2007-05-14 | 2015-05-26 | Medtronic, Inc. | Methods and device to neutralize soluble toxic agents in the brain |
-
2018
- 2018-03-01 EP EP18761409.4A patent/EP3589272A4/en not_active Ceased
- 2018-03-01 AU AU2018226803A patent/AU2018226803A1/en not_active Abandoned
- 2018-03-01 CN CN201880020544.0A patent/CN110545797A/zh active Pending
- 2018-03-01 CA CA3053491A patent/CA3053491A1/en active Pending
- 2018-03-01 JP JP2019547373A patent/JP2020509036A/ja active Pending
-
2023
- 2023-01-20 JP JP2023007457A patent/JP2023071648A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2009151646A3 (en) | Non-invasive diagnostic agents and methods of diagnosing infectious disease | |
| JP2020513032A5 (enExample) | ||
| Ahdab et al. | Rapidly progressive amyotrophic lateral sclerosis initially masquerading as a demyelinating neuropathy | |
| Lekoubou et al. | Effect of long-term oral treatment with L-arginine and idebenone on the prevention of stroke-like episodes in an adult MELAS patient | |
| Schwarz et al. | Fulminant progression of hyperammonaemic encephalopathy after treatment with valproate in a patient with ureterosigmoidostomy | |
| Smyth et al. | An unusual delayed complication of inferior alveolar nerve block | |
| Palareti et al. | Do italian vascular centers look for isolated calf deep vein thrombosis? Analysis of isolated calf deep vein thromboses | |
| JPWO2017146230A1 (ja) | 試験方法 | |
| Boyraz et al. | Thrombosis secondary to penetration of internal carotid artery due to soft palate impalement injury: a case report of hemiplegic syndrome and literature review | |
| Ramesh et al. | Systemic involvement in leprosy | |
| Muthaffar et al. | Acute hemiplegia as a rare presentation of infantile Guillain-Barre syndrome | |
| Zushi et al. | Osteonecrosis of the jaw in an AIDS patient: a case report | |
| Sniedze et al. | Cystic echinococcosis: epidemilogical and clinical aspects of latvian population and review of the literature | |
| Zhao et al. | Nitrous oxide induced subacute combined degeneration | |
| Masmoudi et al. | Diabetes-related distress and its associated factors among patients with type 2 diabetes mellitus in Tunisia | |
| O'Donnell et al. | Lung function and exercise impairment in patients with GOLD stage I and II COPD | |
| Ibrahim et al. | Neuromyotonia (Isaacs' syndrome) in a patient with shistosomaiasis with good response to plasmapharesis: a case report | |
| Jarmoc et al. | Anisocoria after open reduction and internal fixation of a mandible fracture under general anesthesia: a case report | |
| Nair et al. | An adult with atrial septal defect presenting with a brain abscess | |
| Pisciotta et al. | P4. 15 A novel GDAP1 mutation in autosomal dominant Charcot-Marie-Tooth disease | |
| YALINAY DİKMEN et al. | A case with cramp-fasciculation syndrome | |
| Leci et al. | Effects Of SC Treprostinil On Top Of Double Oral Combination Therapy In Patients With Pulmonary Arterial Hypertensione (PAH) And Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) | |
| Sharratt et al. | G132 Co-morbidities in children and young people with chronic idiopathic pain syndrome | |
| Edwards et al. | Reply: Evidence against volume conduction to explain normal MEPs in muscles with low motor power in SCI | |
| Silva et al. | Imaging clinical case |